ST诺泰(688076.SH)子公司通过药品GMP符合性检查

Core Viewpoint - ST诺泰's subsidiary, Hangzhou Ausino Biotechnology Co., Ltd., has successfully passed the GMP compliance inspection for its active pharmaceutical ingredient, Aogtewei Sodium, marking a significant milestone in its production capabilities and quality management system [1] Group 1 - The Zhejiang Provincial Drug Administration issued a GMP compliance inspection notice to Ausino, confirming the successful inspection of the raw material production line at the Jiande factory [1] - The company emphasizes its commitment to "time-leading and technology-leading" business philosophy, which underpins its operational strategies [1] - The successful GMP compliance is seen as a milestone for the company's CDMO business, extending its value from advanced intermediates to raw materials [1]